Connect with us
In the first half of the year, Novo Nordisk saw significant growth in sales, with Ozempic revenue up 36% to 56.685 billion crowns (€7.596 billion) and...
Until now, in the field of anti-obesity treatments, there was a drug that attracted attention: Ozempic. It is also made by Novo Nordisk and is very...
The demand for products indicated against diabetes has increased. Large groups in the sector announced new investment plans to grow in this segment. However, not everything...
Novo Nordisk plans a €2.1 billion investment to strengthen its presence in France's industrial sector, according to French President. The biotech company aims to expand the...
More than half of the population of the countries of the Organization for Economic Cooperation and Development (OECD) was overweight or obese, according to the latest...